BIOXBasic Materials · Agricultural InputsBIOX Stock Forecast: Bioceres Crop Solutions Corp. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 16 of 100 as at 2 Sept 2026 — in the weakest quartile.
BIOX stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Bioceres Crop Solutions Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (89): The share count has been shrinking and the company is not leaning on new borrowing.
Momentum (3): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
BIOX stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on BIOX, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 2 Jan 2026 | Canaccord Genuity | Maintains | Hold | $2.25 → $2.00 |
| 2 Jan 2026 | Canaccord Genuity | Maintains | Hold | — |
| 14 Nov 2025 | Canaccord Genuity | Maintains | Hold | — |
| 10 Sept 2025 | Canaccord Genuity | Downgrade | Hold | — |
| 10 Sept 2025 | Lake Street | Maintains | Buy | — |
| 15 July 2025 | Oppenheimer | Maintains | Outperform | — |
| 22 Apr 2025 | Oppenheimer | Maintains | Outperform | — |
| 13 Feb 2025 | Canaccord Genuity | Maintains | Buy | — |
| 7 Feb 2025 | Canaccord Genuity | Maintains | Buy | — |
| 7 Feb 2025 | Lake Street | Maintains | Buy | — |
| 28 Jan 2025 | Oppenheimer | Maintains | Outperform | — |
| 13 Nov 2024 | Canaccord Genuity | Maintains | Buy | — |
| 21 Oct 2024 | Oppenheimer | Maintains | Outperform | — |
| 17 Oct 2024 | Canaccord Genuity | Maintains | Buy | — |
| 11 Sept 2024 | Canaccord Genuity | Maintains | Buy | — |
| 11 Sept 2024 | Lake Street | Maintains | Buy | — |
| 11 Sept 2024 | Oppenheimer | Maintains | Outperform | — |
| 11 Sept 2024 | Roth MKM | Maintains | Buy | — |
| 19 July 2024 | Canaccord Genuity | Assumes | Buy | $17 |
| 2 July 2024 | Roth MKM | Reinstates | Buy | $15 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BIOX appears on the weeks it earns a place.
BIOX vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 3 Sept 2026, Bioceres Crop Solutions Corp. returned −85.1% against +21.4% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
BIOX analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Bioceres Crop Solutions Corp. (BIOX) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 227.0×
- Price / sales
- 0.1×
- Price / book
- 0.4×
- EV / EBITDA
- −72.0×
Cheaper than 3% of US stocks
Cheaper than 96% of US stocks
Cheaper than 88% of US stocks
Cheaper than 95% of US stocks
- Revenue growth (YoY)
- −35.9%
- Earnings growth (YoY)
- −35.9%
- Gross margin
- 33.2%
- Operating margin
- −20.9%
- Net margin
- −96.9%
Higher than 7% of US stocks
Higher than 14% of US stocks
Higher than 40% of US stocks
Higher than 21% of US stocks
Higher than 6% of US stocks
- Return on equity
- −32.2%
- Return on assets
- −0.9%
- Dividend yield
- —
Higher than 26% of US stocks
Higher than 40% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
Bioceres Crop Solutions Corp. (BIOX) statistics: revenue, profit & scale
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Bioceres Crop Solutions Corp. has a market value of $28.5M and an enterprise value of $280.4M.
Revenue in the twelve months to 31 Mar 2026: $263.7M. The latest quarter shrank 35.9% year on year.
Net income over the same four quarters: −$251.6M, a −95.4% net margin.
Diluted earnings per share, trailing twelve months: $−3.84.
Trailing P/E: 227.0×; forward P/E: 0.7× — the forward figure prices analyst consensus estimates, not reported earnings.
Bioceres Crop Solutions Corp. employs 751 people — $351K of revenue per employee.
Data provided by Twelve Data
BIOX vs competitors
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| BIOXBioceres Crop Solutions Corp. | $28.5M | 16 |
| SEEDOrigin Agritech Ltd. | $12.4M | 22 |
| AVDAmerican Vanguard Corp. | $67.5M | 38 |
| NXTSNexentis Technologies, Inc. | $2.5M | 2 |
| IPIIntrepid Potash, Inc. | $555.1M | 89 |
| LOOPLoop Industries, Inc.* | $24.6M | 15 |
| MERCMercer International, Inc.* | $24.0M | 9 |
* Nearest Basic Materials names by size — few agricultural inputs companies of this scale trade in the US universe.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Bioceres Crop Solutions Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about BIOX stock
Is BIOX stock a buy right now?
Of the 1 analysts covering Bioceres Crop Solutions Corp., 0 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Bioceres Crop Solutions Corp. 16 out of 100 across roughly 4,600 US stocks as at 2 Sept 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank BIOX?
As at 2 Sept 2026, Bioceres Crop Solutions Corp. ranks 16 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (89 of 100).
What is the BIOX stock forecast for 2030?
No analyst covering Bioceres Crop Solutions Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BIOX are extrapolating price history, which says nothing about the business.
How has BIOX stock performed over the past year?
Bioceres Crop Solutions Corp. returned -85.1% over the 12 months to 3 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Bioceres Crop Solutions Corp. do?
Bioceres Crop Solutions Corp. is an agricultural biotechnology company that develops and commercializes crop productivity solutions for farmers and agribusinesses.
About Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp. is an agricultural biotechnology company that develops and commercializes crop productivity solutions for farmers and agribusinesses. Its portfolio includes seeds, seed traits, seed treatments, biological inputs, crop protection products, and crop nutrition solutions designed to improve crop performance and resilience. The company operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments, giving it a broad platform across the agricultural input value chain. Bioceres Crop Solutions also offers HB4 drought-tolerant seed technology, supporting crops used in major row-crop markets. With operations and product sales across multiple regions, the company serves customers in South America, North America, Europe, Africa, and other international markets. Bioceres Crop Solutions Corp. plays a role in modern agriculture by combining biotechnology, biologicals, and input technologies to support more efficient crop production.
CEO Dr. Federico Trucco Ph.D. · 751 employees · Argentina · https://investors.biocerescrops.com/home/default.aspx